Introduction

Pyospermia – also known as leukocytospermia – refers to the presence of an excessive number of white blood cells (WBCs) in semen, which often indicates an underlying inflammatory process in the male reproductive system. Defined as the presence of more than 1 million WBCs per millilitre of semen, pyospermia is associated with male infertility and impaired sperm quality.

Understanding the markers of inflammation in seminal plasma and how these markers influence male reproductive health is crucial for both diagnosing and managing male infertility. Pyospermia is typically detected during routine semen analysis, which is used to evaluate sperm parameters for infertility diagnosis. One of the key contributors to pyospermia is inflammation in the male reproductive tract, which can be due to infections or other medical conditions.

Seminal plasma analysis provides a comprehensive view of the underlying pathophysiological processes in pyospermia by identifying various biomarkers of inflammation, such as cytokines, chemokines, and reactive oxygen species. These markers are essential for understanding the role of inflammation in sperm dysfunction and infertility. By identifying specific inflammatory markers, clinicians can develop targeted treatments for affected individuals, potentially improving fertility outcomes.

This article explores:

• The causes and risk factors of pyospermia
• The role of seminal plasma in male reproductive health
• The inflammatory markers present in seminal plasma
• Diagnostic techniques and clinical implications of pyospermia, as well as ongoing research in this area

Causes and risk factors of pyospermia

Infections

One of the primary causes of pyospermia is infections in the male reproductive tract, including the prostate, seminal vesicles, epididymis, and testes. Infections lead to the recruitment of white blood cells to the site of infection, resulting in pyospermia. Common pathogens associated with pyospermia include Chlamydia trachomatis, Neisseria gonorrhoeae, Escherichia coli, and Ureaplasma urealyticum.^1,2 These pathogens can cause localised inflammation, often leading to prostatitis or epididymitis, which increases WBC count in semen. These infections can significantly reduce sperm motility, morphology, and DNA integrity, contributing to male infertility.³

Lifestyle factors

Lifestyle factors, such as smoking, excessive alcohol consumption, poor diet, and high stress, have been shown to increase the risk of pyospermia. Smoking, for example, is associated with increased oxidative stress and inflammation, which can elevate WBCs in semen.⁴ Excessive alcohol consumption has a similar effect, impairing the immune response and increasing the production of inflammatory mediators.⁵ Poor dietary habits, particularly a diet low in antioxidants, can exacerbate inflammation, further increasing the risk of pyospermia and infertility.

Medical conditions

Various medical conditions, such as varicocele, chronic diseases, and autoimmune disorders, may also predispose the development of pyospermia.^6,7 Varicocele, a condition where the veins in the scrotum become enlarged, is one of the most common causes of male infertility. It has been associated with an increase in testicular temperature, oxidative stress, and inflammation, contributing to pyospermia.⁸ Autoimmune disorders can also lead to the production of autoantibodies against sperm or other components of the male reproductive system, inducing inflammation in the seminal plasma and increasing WBCs in semen.⁹

Role of seminal plasma in male reproductive health

Composition of seminal plasma

Seminal plasma is the fluid component of semen that supports and nourishes sperm. It is composed of secretions from the prostate, seminal vesicles, bulbourethral glands, and epididymis. Seminal plasma contains various enzymes, proteins, hormones, lipids, and other bioactive molecules, which are crucial for sperm motility, viability, and protection from oxidative damage.¹⁰ This complex composition plays a significant role in maintaining sperm health and facilitating fertilisation.

Functions of seminal plasma

The primary functions of seminal plasma are to protect, nourish, and transport sperm. It provides a medium in which sperm can swim toward the egg during fertilisation. Additionally, seminal plasma contains antioxidants that protect sperm from oxidative damage, an important factor in male fertility. Furthermore, it acts as a buffer, maintaining the pH balance necessary for sperm motility. Inflammatory markers in seminal plasma, such as cytokines and ROS, can disrupt these functions, leading to sperm dysfunction and infertility.

Inflammatory markers in seminal plasma

Cytokines and chemokines

Cytokines and chemokines are signalling molecules that mediate the inflammatory response and are critical markers of inflammation in seminal plasma. The most commonly studied cytokines in semen are interleukin 6 (IL-6), interleukin 8 (IL-8) and tumour necrosis factor alpha (TNF-α). These cytokines are produced in response to infection, injury or other forms of inflammation in the male reproductive system. Elevated levels of IL-6 and IL-8 have been associated with increased WBC count in semen, as well as impaired sperm motility and morphology.^11,12

IL-6, in particular, plays a role in the pathogenesis of male infertility by inhibiting sperm function and inducing oxidative stress.¹³ IL-8 is a chemokine that attracts neutrophils to sites of infection and inflammation, further increasing the WBC count in semen. TNF-α is another pro-inflammatory cytokine, which is implicated in sperm DNA fragmentation and reduced fertility.¹⁴ These cytokines are important biomarkers for diagnosing pyospermia and understanding the underlying inflammation.

Reactive oxygen species (ROS)

Reactive oxygen species (ROS) are highly reactive molecules that are produced as a result of metabolism and immune response. In seminal plasma, ROS are primarily generated by leukocytes and defective sperm.¹⁵ While ROS are essential for normal sperm function, excessive ROS production can lead to oxidative stress. This damages sperm DNA, proteins, and lipids, leading to impaired sperm motility and fertilising ability.

Elevated ROS levels are often observed in pyospermia and are strongly correlated with male infertility.¹⁶ The oxidative stress caused by excessive ROS can lead to lipid peroxidation in sperm membranes, impairing sperm motility and inducing apoptosis (e.g., programmed cell death).¹⁷ ROS levels in seminal plasma can be measured using various methods, such as chemiluminescence or electron spin resonance spectroscopy, to assess the degree of oxidative stress and its impact on sperm function.¹⁸

Enzymatic markers

Enzymatic markers – such as myeloperoxidase (MPO) and elastase – are key indicators of neutrophil activity in seminal plasma. Neutrophils are a type of white blood cell that play a key role in the immune response to infection. MPO is an enzyme produced by neutrophils that catalyses the production of ROS during inflammation. Elevated levels of MPO in seminal plasma are often associated with pyospermia and are indicative of ongoing inflammation in the male reproductive tract.¹⁹

Elastase – another enzyme released by neutrophils – can also degrade sperm proteins and impair sperm function. The presence of these enzymatic markers in seminal plasma is strongly correlated with pyospermia and serves as a useful diagnostic tool for identifying inflammation-related infertility.²⁰

Other biomarkers

In addition to cytokines, ROS, and enzymatic markers, several other biomarkers are also associated with inflammation in seminal plasma. C-reactive protein (CRP), a general marker of systemic inflammation, gets elevated in the semen of infertile men with pyospermia.²¹ Antioxidant markers, such as total antioxidant capacity (TAC) and superoxide dismutase (SOD), are also important indicators of oxidative stress and inflammation in seminal plasma.²² A balance between pro-inflammatory markers (e.g., cytokines, ROS) and anti-inflammatory markers (e.g., antioxidants) is essential for maintaining optimal sperm health.

Diagnostic techniques and laboratory analysis

Semen analysis and WBC identification

Semen analysis is the primary diagnostic tool for evaluating male fertility and identifying pyospermia. The World Health Organisation (WHO) guidelines for semen analysis provide standardised methods for assessing sperm count, motility, morphology, and the presence of WBCs. Pyospermia is diagnosed when the WBC count exceeds 1 million cells per millilitre of semen. WBCs can be detected using microscopy or special staining techniques (e.g., the peroxidase Endtz test, which detects the presence of leukocytes).²³

Seminal plasma separation

To analyse biomarkers in seminal plasma, semen is typically centrifuged to separate the spermatozoa from the seminal plasma. This facilitates the collection of seminal plasma, enabling further analysis of inflammatory markers. Proper handling and storage of seminal plasma samples are crucial to preserve the integrity of biomarkers.²⁴

Biomarker detection techniques

Several laboratory techniques are used to detect and quantify inflammatory biomarkers in seminal plasma. Enzyme-linked immunosorbent assays (ELISA) are often employed to measure the levels of specific cytokines, such as IL-6, IL-8, and TNF-α.²⁵ Flow cytometry is another technique used to assess the phenotype of immune cells, such as leukocytes, in seminal plasma. Western blotting and reverse transcription polymerase chain reaction (RT-PCR) can be used to detect specific proteins and gene expression related to inflammation.²⁶

Chemiluminescence assays are often employed to measure ROS levels in seminal plasma, providing insight into the degree of oxidative stress present. These methods assist clinicians in identifying the specific inflammatory markers contributing to pyospermia, further guiding treatment strategies.

Clinical implications and management

Relationship between inflammation and infertility

Inflammation in the male reproductive system plays a significant role in male infertility. The presence of excess WBCs in semen can impair sperm motility, reduce sperm morphology, and increase DNA fragmentation, all of which contribute to infertility.²⁷ Inflammation-induced oxidative stress further exacerbates sperm damage, leading to reduced fertilisation potential. The identification of inflammatory markers in seminal plasma can help clinicians assess the degree of sperm damage and guide treatment strategy.

Treatment approaches

Management of pyospermia involves addressing the underlying cause of inflammation. In cases where infections are identified, antibiotics or antiviral treatments are used to target the specific pathogens responsible for inflammation. Anti-inflammatory agents, such as corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs), may also be used to reduce inflammation and improve sperm quality.²⁸

Antioxidant supplementation, including vitamins C and E, has been proven to reduce oxidative stress in seminal plasma, potentially improving sperm motility and reducing DNA fragmentation.²⁹ In addition, lifestyle modifications (e.g., smoking cessation, reduced alcohol consumption, and maintaining a balanced, healthy diet) can help reduce inflammation and improve male fertility outcomes.

Monitoring treatment outcomes

After initiating treatment for pyospermia, it is important to monitor changes in seminal plasma biomarkers and semen parameters. A follow-up semen analysis can help assess the effectiveness of the treatment in reducing WBC count and improving sperm quality. Monitoring inflammatory markers, such as cytokine levels and ROS production, can provide valuable insights into treatment progress and further guide management decisions.³⁰

Research and future directions

Emerging biomarkers in male infertility

Advancements in proteomics and metabolomics have led to the discovery of novel biomarkers associated with inflammation in seminal plasma. These emerging biomarkers may provide new insights into the mechanisms underlying pyospermia and male infertility, offering more specific diagnostic and therapeutic targets.³¹

Need for standardisation

There is a need for standardised protocols for measuring and interpreting inflammatory markers in seminal plasma. Establishing consistent diagnostic thresholds and clinical guidelines for pyospermia will improve diagnosis and treatment outcomes.³²

Personalised medicine approach

Future research should focus on developing personalised treatment strategies based on individual biomarker profiles. By tailoring treatment plans to the specific inflammatory markers present in each patient, clinicians can enhance therapeutic efficacy and improve fertility outcomes.³³

Summary

• Pyospermia refers to the presence of an excessive number of white blood cells (WBCs) in semen, which often indicates an underlying inflammatory process in the male reproductive system
• Pyospermia is a key indicator of inflammation in the male reproductive tract and is closely linked to male infertility
• Seminal plasma analysis offers an effective and non-invasive method for identifying inflammatory markers that play a key role in sperm dysfunction (e.g., cytokines, reactive oxygen species and enzymatic markers)
• Understanding the causes, diagnostic methods, and clinical implications of pyospermia is essential for managing male infertility
• Ongoing research into emerging biomarkers and personalised treatment approaches holds promise for improving the diagnosis and management of inflammation-related male infertility.